COAPT Risk Score
COAPT Risk Score is a medical calculator for cardiologists, providing 2-year risk assessments for patients with functional mitral regurgitation on iOS and Android.
The App DNA
What makes this app unique?
The tool provides a standardized prognostic model derived from the COAPT trial, removing the cognitive friction of manual risk calculation for heart teams.
For Medical professionals, cardiologists, and heart teams managing patients with functional mitral regurgitation.
What does it look like?
Key features
Predicts 2-year risk of death and heart failure hospitalization using clinical and echocardiographic variables.
Incorporates transcatheter edge-to-edge repair data into prognostic risk modeling to support clinical decision-making.
How much does it cost?
The app is a free clinical utility sponsored by Abbott to support medical decision-making.
Velocity
Dormant developmentperformanceShow more...
COAPT Risk Score has been inactive for 849 days, indicating a complete cessation of development. The last release was a minor update focused on platform compatibility, and no subsequent feature builds or maintenance patches have been deployed. The project currently shows no signs of active support or ongoing development.
Who built it?
Cardiology Apps
7 apps tracked · Medical
IVUSAID
HemodynamicAID
AngioAID 3D
IVUSAID
DeviceAID
MCSAIDUser Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for COAPT Risk Score
How's the Medical market?
COAPT Risk Score operates as a niche medical utility, maintaining a 5-star rating on iOS with a single review. The lack of recent updates since May 2024 signals a maintenance-mode posture rather than active market expansion.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for COAPT Risk Score
Where is it heading?
The market for specialized medical calculators is consolidating around evidence-based tools that integrate directly into clinical workflows. COAPT Risk Score remains stable, but its long-term utility depends on its ability to reflect the latest clinical trial data.
- The tool remains in maintenance mode with no updates since 2024, signaling a focus on stability over feature expansion.
The SWOT
- Clinical prognostic model derived from the COAPT trial population
- TEER integration enables shared decision-making for complex heart failure cases
- Expansion into broader heart failure prognostic modeling could increase the addressable user base
Next best moves
Audit clinical data against current guidelines because the tool has not been updated since 2024 → ensure prognostic accuracy
The counter-intuitive read
The lack of updates is a feature, not a bug…
Read the full takeBottom line
The tool provides a specialized clinical utility that remains valuable for its specific trial-based prognostic model. Maintaining the tool's accuracy against current clinical guidelines is the primary requirement to preserve its utility for heart teams.
Unlock 2 critical frictions, 1 market threat and the analyst’s take.
Access the full report for freeSources
- [1] App Store
- [2] Developer website, source
- [3] Play Store
Report last updated